Oct. 2015: Delta Air Lines (Stock to Study), Biogen (Undervalued)The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Delta Air Lines, Inc. (NYSE: DAL) as its October 2015 "Stock to Study" and Biogen Inc. (NDQ: BIIB) as its October 2015 "Undervalued Stock" for investors' informational and educational use.
"The committee selected Delta Air Lines for its high expected earnings growth over the next five years combined with reasonable valuation," said Adam Ritt, editor of BetterInvesting Magazine. "For the Undervalued selection, the committee cited Biogen's current price-earnings ratio, which is lower than many of its biotech peers, and strong growth opportunities." Check BetterInvesting's October issue for more details about these selections.
Committee members are Kenneth M. Bernard, CFA; Robert M. Bilkie, Jr., CFA; Daniel J. Boyle, CFA; Marisa Bradbury, CFA; Philip S. Dano, CFA; Donald E. Danko, CFA; Maury Elvekrog, CFA; and Walter J. Kirchberger, CFA.
As stated, the BetterInvesting committee's Stock to Study and Undervalued Stock choices are for the informational and educational uses of investors and are not intended as investment recommendations. BetterInvesting urges investors to educate themselves about the stock market so they can make informed decisions about stock purchases.